PRIMAXINIV (Cardinal Health)


Welcome to the PulseAid listing for the PRIMAXIN drug offered from Cardinal Health. This Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: imipenem and cilastatin sodium
SUBSTANCE NAME: IMIPENEM; CILASTATIN SODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1987-01-08
END MARKETING DATE: 0000-00-00


PRIMAXIN IV HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPRIMAXIN IV from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 500; 500(mg/100mL; mg/100mL)
START MARKETING DATE: 1987-01-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-5019_ebcb1bef-463a-4503-b847-68d45d0aced6
PRODUCT NDC: 55154-5019
APPLICATION NUMBER: ANDA062756

Other IMIPENEM; CILASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthImipenem and Cilastatin
Fresenius Kabi USA, LLCImipenem and Cilastatin
Hospira, Inc.Imipenem and Cilastatin
Merck Sharp & Dohme Corp.PRIMAXIN